You are here

Article info

Article menu
Download PDFPDF
Clinical science
ACE inhibitor use and risk of cataract: a case–control analysis

Authors

  • Claudia Becker Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland Hospital Pharmacy, University Hospital Basel, Basel, Switzerland PubMed articlesGoogle scholar articles
  • Susan S Jick Boston Collaborative Drug Surveillance Program, Lexington, Massachusetts, USA School of Public Health, Boston University, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Christoph R Meier Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland Hospital Pharmacy, University Hospital Basel, Basel, Switzerland Boston Collaborative Drug Surveillance Program, Lexington, Massachusetts, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Christoph R Meier, Basel Pharmacoepidemiology Unit, Hospital Pharmacy, University Hospital Basel, Basel 4051, Switzerland; Christoph.Meier{at}usb.ch
View Full Text

Citation

Becker C, Jick SS, Meier CR
ACE inhibitor use and risk of cataract: a case–control analysis
British Journal of Ophthalmology 2019;103:1561-1565.

Publication history

  • Received July 31, 2018
  • Revised December 18, 2018
  • Accepted December 26, 2018
  • First published February 7, 2019.
Online issue publication 
October 23, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.